WHO ICTRP trial
A prospective, randomized, multicenter, interventional study to evaluate the…
NL-OMON39773 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON39773 |
|---|---|
| Public title | A prospective, randomized, multicenter, interventional study to evaluate the safety and effectiveness of the TactiCath® percutaneous ablation catheter for the treatment of symptomatic paroxysmal atrial fibrillation using contact force assisted irrigated radiofrequency ablation |
| Scientific title | A prospective, randomized, multicenter, interventional study to evaluate the safety and effectiveness of the TactiCath® percutaneous ablation catheter for the treatment of symptomatic paroxysmal atrial fibrillation using contact force assisted irrigated radiofrequency ablation - Toccastar |
| Primary sponsor | St. Jude Medical GVA Sàrl |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Czechia;France;Germany;Italy;Netherlands ;Switzerland;United Kingdom;United States of America |
| Conditions | atrial fibrillation;10007521;atrial fibrillation |
| Interventions | The following evaluations will be done as per the protocol requirements (not standard of care) Baseline Evaluations: Determination of the NYHA functional class Quality of life assessment Pregnancy test (women of childbearing potential)… |
| Registration date | Sep 4, 2014 |
| Target size | 15 |
| Secondary IDs | NL34761.078.11 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: